Clinical Trials Logo

Skin Diseases, Infectious clinical trials

View clinical trials related to Skin Diseases, Infectious.

Filter by:

NCT ID: NCT00488761 Completed - Clinical trials for Skin Diseases, Infectious

Study Evaluating the Safety and Efficacy of Tigecycline in Hospitalized Patients With cSSSI

Start date: July 2006
Phase: Phase 4
Study type: Interventional

Tigecycline's activity against resistant organisms, as well as significant coverage of both gram-positive and gram-negative bacteria, may provide a valuable therapeutic alternative in treating patients with complicated skin and/or skin structure infections.

NCT ID: NCT00488345 Completed - Clinical trials for Bacterial Infections

Study Evaluating the Pharmacokinetics (PK), Safety, and Tolerability of Tigecycline in Patients 8 to 11 Years of Age

Start date: December 2007
Phase: Phase 2
Study type: Interventional

To determine the pharmacokinetic profile and to evaluate the safety and tolerability of ascending multiple doses of tigecycline in patients aged 8 to 11 years with selected serious infections; complicated intra-abdominal infections (cIAI), complicated skin and skin structure infections (cSSSI), or community-acquired pneumonia (CAP).

NCT ID: NCT00475930 Completed - Clinical trials for Staphylococcus Aureus

Chlorhexidine Impregnated Cloths to Prevent Skin and Soft Tissue Infections in Marine Officer Candidates

Start date: May 2007
Phase: N/A
Study type: Interventional

Outbreaks of skin and soft tissue infections (SSTI) related to community associated Methicillin-resistant Staphylococcus aureus (MRSA) have become increasingly common in military training units. Risk factors for MRSA related SSTI such as crowding, poor hygiene and shared equipment are often hard to avoid in a military training environment, often designed to simulate battlefield conditions. It has recently been demonstrated that military recruits colonized with MRSA may be at increased risk of developing SSTI. Studies in the hospital environment have shown that decolonizing inpatients known to carry MRSA decreases the rates of MRSA related infections in the treated individuals and also in their inpatient unit as a whole. The investigators propose a randomized, double blind, placebo controlled trial to: 1. Evaluate the effectiveness, feasibility, and safety of chlorhexidine body cloths, self-administered three times weekly, in preventing SSTI among recruits in military training facilities; and 2. Evaluate the effectiveness of chlorhexidine body cloths in decreasing rates of Staphylococcus aureus colonization among military recruits.

NCT ID: NCT00442832 Completed - Clinical trials for Staphylococcal Skin Infection

TD-1792 in Gram-positive Complicated Skin and Skin Structure Infection

Start date: December 2006
Phase: Phase 2
Study type: Interventional

The purpose of this study is to determine whether TD-1792 is safe and effective when used to treat complicated skin and skin structure infections caused by Gram-positive bacteria.

NCT ID: NCT00388310 Completed - Clinical trials for Skin Diseases, Infectious

Effective Antibiotic Treatment of MRSA

Start date: February 2006
Phase: N/A
Study type: Interventional

To evaluate the effective duration (in days) to clinical improvement of outpatient antibiotic regimens in the treatment of superficial abscesses caused by MRSA in patients that present to the emergency department.

NCT ID: NCT00352612 Completed - Abscess Clinical Trials

Comparison of Cephalexin Versus Clindamycin for Suspected CA-MRSA Skin Infections

Start date: September 2006
Phase: Phase 4
Study type: Interventional

The purpose of this study is to help define the role of antibiotics in the treatment of pediatric skin infections caused by community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA). The investigators hypothesize that treatment with cephalexin, a penicillin-like antibiotic to which CA-MRSA would be expected to be resistant, does not result in poorer outcomes than treatment with clindamycin, an antibiotic to which CA-MRSA is most often susceptible.

NCT ID: NCT00343135 Completed - Clinical trials for Skin Diseases, Infectious

AUGMENTIN 1gm In Skin And Soft Tissue Infection

Start date: December 2004
Phase: Phase 4
Study type: Interventional

Study to evaluate the effects of AUGMENTIN 1gm in the treatment of Skin and Soft tissue infections

NCT ID: NCT00257062 Completed - Clinical trials for Skin Diseases, Infectious

A Study of the Safety and Effectiveness of Oral Levofloxacin Compared With Oral Ciprofloxacin in the Treatment of Adults With Uncomplicated Infections of the Skin and the Supportive Layers Beneath the Skin

Start date: January 1993
Phase: Phase 3
Study type: Interventional

The purpose of this study is to evaluate the safety and effectiveness of levofloxacin, an antibiotic, compared with another antibiotic, ciprofloxacin, in the treatment of adults with uncomplicated infections of the skin and the supportive layers beneath the skin.

NCT ID: NCT00257036 Completed - Cellulitis Clinical Trials

A Study of the Safety and Effectiveness of Oral Levofloxacin Compared With Oral Ciprofloxacin in the Treatment of Adults With Mild to Moderate Infections of the Skin and the Supportive Layers Beneath the Skin

Start date: July 1991
Phase: Phase 2/Phase 3
Study type: Interventional

The purpose of this study is to evaluate the safety and effectiveness of levofloxacin, an antibiotic, compared with ciprofloxacin, another antibiotic, in the treatment of adults with mild to moderate infections of the skin and the supportive layers beneath the skin.

NCT ID: NCT00228982 Completed - Clinical trials for Skin Diseases, Infectious

Ceftobiprole in the Treatment of Resistant Staphylococcus Aureus Skin and Skin Structure Infections

Start date: October 2004
Phase: Phase 3
Study type: Interventional

The purpose of this study is to compare the clinical cure rate of ceftobiprole medocaril versus a comparator in the treatment of patients with complicated skin and skin structure infections.